F859-0150 Screening compound: N-[(4-ethylphenyl)methyl]-2-[N-methyl1-(butan-2-yl)-1H-1,2,3-benzotriazole-5-sulfonamido]acetamide

F859-0150 Screening compound: N-[(4-ethylphenyl)methyl]-2-[N-methyl1-(butan-2-yl)-1H-1,2,3-benzotriazole-5-sulfonamido]acetamide
F859-0150 Screening compound: N-[(4-ethylphenyl)methyl]-2-[N-methyl1-(butan-2-yl)-1H-1,2,3-benzotriazole-5-sulfonamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F859-0150
N-[(4-ethylphenyl)methyl]-2-[N-methyl1-(butan-2-yl)-1H-1,2,3-benzotriazole-5-sulfonamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F859-0150

Molecular Formula

C22H29N5O3S (C22 H29 N5 O3 S)

Compound Name

N-[(4-ethylphenyl)methyl]-2-[N-methyl1-(butan-2-yl)-1H-1,2,3-benzotriazole-5-sulfonamido]acetamide

IUPAC name

N-[(4-ethylphenyl)methyl]-2-[N-methyl1-(butan-2-yl)-1H-123-benzotriazole-5-sulfonamido]acetamide

SMILES

CCC(C)n1nnc2c1ccc(S(N(C)CC(NCc1ccc(CC)cc1)=O)(=O)=O)c2

InChI

InChI=1S/C22H29N5O3S/c1-5-16(3)27-21-12-11-19(13-20(21)24-25-27)31(29,30)26(4)15-22(28)23-14-18-9-7-17(6-2)8-10-18/h7-13,16H,5-6,14-15H2,1-4H3,(H,23,28)/t16-/m0/s1

InChI Key

YWYUKNYEDYQSOL-INIZCTEOSA-N

MDL Number (MFCD)

MFCD14968314

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

443.57

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.507

Distribution Coefficient, logD

3.507

Water Solubility, LogSw

-3.84

Polar Surface Area

83.025

Acid Dissociation Constant (pKa)

12.31

Base Dissociation Constant (pKb)

0.53

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.90

F859-0150 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with F859-0150 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F859-0150?
Check Price and Availability of F859-0150, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F859-0150 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F859-0150
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F859-0150
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F859-0150 available by request